title: Surveillance and monitoring of adult cancer survivors.
abstract: Advances in early detection and treatment have improved survival in common adult cancers. Surveillance for late recurrence and secondary primary malignancies is recommended for most patients. Initial treatment with surgery, radiation, chemotherapy, or hormonal therapy can result in both local and systemic sequelae, including treatment-related new cancers. Patients with head and neck, lung, breast, colorectal, and prostate cancers constitute the largest groups requiring long-term monitoring and follow-up care.
authors.affiliation: Department of Oncology, Wayne State University, Karmanos Cancer Institute, Detroit, Mich., USA. choim@karmanos.org
authors.forename: Minsig
authors.initials: M
authors.lastname: Choi
authors.forename: Barbara
authors.initials: B
authors.lastname: Craft
authors.forename: Stephen A
authors.initials: SA
authors.lastname: Geraci
mesh_terms: D000328:Adult; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects; D001943:Breast Neoplasms / Q000175:diagnosis; D017024:Chemotherapy, Adjuvant / Q000009:adverse effects; D015179:Colorectal Neoplasms / Q000175:diagnosis; D055088:Early Detection of Cancer; D005260:Female; D006258:Head and Neck Neoplasms / Q000175:diagnosis; D006331:Heart Diseases / Q000209:etiology; D006801:Humans; D008175:Lung Neoplasms / Q000175:diagnosis; D008297:Male; D008403:Mass Screening / Q000379:methods / Q000592:standards; D009364:Neoplasm Recurrence, Local / Q000175:diagnosis* / Q000453:epidemiology / Q000517:prevention & control / Q000628:therapy; D009369:Neoplasms / Q000188:drug therapy / Q000532:radiotherapy / Q000601:surgery / Q000628:therapy*; D016609:Neoplasms, Second Primary / Q000175:diagnosis* / Q000453:epidemiology / Q000517:prevention & control / Q000628:therapy; D010523:Peripheral Nervous System Diseases / Q000209:etiology; D011159:Population Surveillance / Q000379:methods; D011471:Prostatic Neoplasms / Q000175:diagnosis; D018714:Radiotherapy, Adjuvant / Q000009:adverse effects; D012307:Risk Factors; D017741:Survivors / Q000706:statistics & numerical data; D013997:Time Factors
chemical_list: D000970:Antineoplastic Agents